Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diversified world: drive to life's origin?!

Hans Kuhn1, Christoph Kuhn

  • 1Gruppe Biophysik, Institut für Molekularbiologie und Biophysik, Eidgenössische Technische Hochschule Hönggerburg, 87093 Zurich, Switzerland.

Angewandte Chemie (International Ed. in English)
|January 28, 2003
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry].

Zeitschrift fur Rheumatologie·2025
Same author

Potential of digital applications for self-management and other outcomes in inflammatory rheumatic diseases: a systematic literature review.

Frontiers in medicine·2025
Same author

RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings.

Rheumatology international·2025
Same author

Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Rheumatology international·2025
Same author

Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective study.

Frontiers in immunology·2024
Same author

Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR network.

Rheumatology international·2024